• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Clinical Operations Services
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On-Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Careers
    • Privacy Notice
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Contact Us
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • Thales™
      • Pro-ficiency
      • Panorama KOL Insights Engine
      • MedChem Designer™
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Clinical Operations
      • Medical Communications
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
        • Liver Safety+
        • NAMVantage™
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Clinical Operations Services
      • Medical Communications
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • NAMVantage™
      • Pulmonary Package
    • Concierge
    • Regulatory Strategies Center of Excellence
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On-Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Leadership
    • Board of Directors
    • Partners and Collaborators
    • Careers
    • Privacy Notice
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Contact Us
Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus
View More
Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus
  • February 12, 2007
  • Press Release

Top 5 Pharmaceutical Company Signs Five-Year Extension Of Services Agreement With Simulations Plus

Keywords: five-year extension, oral absorption, pharmaceutical, pharmacokinetics
Division: PBPK

Contract Signals Long-Term Demand for Simulations Plus' Software and Consulting Services

  • Read More
ANTI-HIV Predictive Models Released by Simulations Plus
  • January 31, 2007
  • Press Release

ANTI-HIV Predictive Models Released by Simulations Plus

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, AIDS, anti-HIV agents, Toxicity
Division: PBPK

Extensions to ADMET Predictor(™) Software Enhance Anti-HIV Activity Discovery Capabilities

  • Read More
Simulations Plus to Present at RedChip Investor Conference February 12 in Tempe, Arizona
  • January 25, 2007
  • Press Release

Simulations Plus to Present at RedChip Investor Conference February 12 in Tempe, Arizona

Keywords: investor conference
Division: PBPK
  • Read More
Simulations Plus Reports First Quarter FY2007 Financial Results
  • January 16, 2007
  • Press Release

Simulations Plus Reports First Quarter FY2007 Financial Results

Keywords: financial results, investor relations, net income
Division: PBPK

Record First Quarter Sees Pharmaceutical Revenues Jump 314%

  • Read More
Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call
  • January 10, 2007
  • Press Release

Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Tuesday, January 16, at 4:15 PM EST

  • Read More
Simulations Plus Flagship Software To Aid Government Research Projects
  • January 9, 2007
  • Press Release

Simulations Plus Flagship Software To Aid Government Research Projects

Keywords: in vitro dissolution experiment simulation software, PBPK modeling program, The U.S. Food and Drug Administration
Division: PBPK

U.S. FDA Licenses GastroPlus(™)

  • Read More
Simulations Plus Receives Another Large Pharmaceutical Software License Renewal
  • December 21, 2006
  • Press Release

Simulations Plus Receives Another Large Pharmaceutical Software License Renewal

Keywords: investor relations
Division: PBPK

Large Pharmaceutical Company Renews Global Software Licenses

  • Read More
Simulations Plus Receives Large Multi-Year Pharmaceutical Software License
  • December 14, 2006
  • Press Release

Simulations Plus Receives Large Multi-Year Pharmaceutical Software License

Keywords: in vitro dissolution experiment simulation software, modeling and simulation, Multi-year Agreement, PBPK modeling, Roche
Division: PBPK

Hoffmann-LaRoche Renews Multi-year Software Licenses

  • Read More
Simulations Plus Releases GastroPlus(™) 5.2
  • November 30, 2006
  • Press Release

Simulations Plus Releases GastroPlus(™) 5.2

Keywords: PBPK modeling, pharmacokinetic/pharmacodynamic (PKPD) model, precision, simulation software
Software: GastroPlus®
Division: PBPK

Flagship Software Product Improvements Provide Greater Accuracy and Convenience

  • Read More
Simulations Plus Releases ClassPharmer(™) 4.2
  • November 27, 2006
  • Press Release

Simulations Plus Releases ClassPharmer(™) 4.2

Keywords: chemistry, ClassPharmer, discovery cheminformatics, high throughput screening, The U.S. Food and Drug Administration
Division: PBPK

Improvements Provide New Capabilities Requested by User Community

  • Read More
Simulations Plus Reports Preliminary FY2006 Financial Results
  • November 9, 2006
  • Press Release

Simulations Plus Reports Preliminary FY2006 Financial Results

Keywords: investor relations, preliminary results
Division: PBPK

Annual Revenues Up 23%, Net Earnings Up 158%

  • Read More
Simulations Plus Announces Fiscal Year 2006 Earnings Conference Call
  • November 6, 2006
  • Press Release

Simulations Plus Announces Fiscal Year 2006 Earnings Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Thursday, November 9, at 4:15 PM EST

  • Read More
Investment for Software Acquisitions Recovered in Only 11 Months
  • October 9, 2006
  • Press Release

Investment for Software Acquisitions Recovered in Only 11 Months

Keywords: Bioreason, informatics, investor relations, pharmaceutical acquisition
Division: PBPK
  • Read More
Japan’s NIHS Licenses Simulations Plus ClassPharmer Software for Five Years
  • October 3, 2006
  • Press Release

Japan’s NIHS Licenses Simulations Plus ClassPharmer Software for Five Years

Keywords: Bioreason, ClassPharmer, National Institute of Health Sciences (NIHS)
Division: PBPK

National Institute of Health Sciences is Equivalent to U.S. F.D.A.

  • Read More
Simulations Plus Releases ADMET Predictor(™) 2.0
  • September 20, 2006
  • Press Release

Simulations Plus Releases ADMET Predictor(™) 2.0

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, drug discovery, molecular property prediction software, Toxicity
Software: ADMET Predictor®
Division: PBPK

Powerful Predictive Software Enhanced With Superior Molecular Modeling Capabilities

  • Read More
Simulations Plus Announces Large Consulting Contract
  • August 31, 2006
  • Press Release

Simulations Plus Announces Large Consulting Contract

Keywords: investor relations
Division: PBPK

Company Underscores Guidance at Fiscal Year End

  • Read More
Simulations Plus Stock Splits 2-for-1
  • August 14, 2006
  • Press Release

Simulations Plus Stock Splits 2-for-1

Keywords: investor relations, stock
Division: PBPK

CEO to be Interviewed by the Wall Street Reporter

  • Read More
Simulations Plus CEO Walt Woltosz Live on Market News First
  • August 8, 2006
  • Press Release

Simulations Plus CEO Walt Woltosz Live on Market News First

Keywords: high-throughput screening (HTS), investor relations, Market News First, oral absorption, pharmacokinetics
Division: PBPK
  • Read More
Simulations Plus Announces Stock Dividend
  • July 20, 2006
  • Press Release

Simulations Plus Announces Stock Dividend

Keywords: 1996 Stock Option Plan, investor relations, stock dividend
Division: PBPK

Board of Directors Approves Two-for-One Stock Split

  • Read More
Simulations Plus Reports Third Quarter FY2006 Financial Results
  • July 11, 2006
  • Press Release

Simulations Plus Reports Third Quarter FY2006 Financial Results

Keywords: financial results, investor relations, net revenues
Division: PBPK

Company Sets New Record for Third Quarter Revenues and Earnings

  • Read More
  • «
  • 1
  • 2
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • Thales™
  • MITOsym®
  • QSP Software
  • Pro-ficiency
  • Panorama KOL Insights Engine
  • MedChem Designer™
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Clinical Operations Services
  • Medical Communications Services
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2025 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept